EFS
Showing 1 - 25 of 1,714
High-risk Percutaneous Coronary Intervention, Heart Disease, Coronary Trial (VITALYST System)
Not yet recruiting
- High-risk Percutaneous Coronary Intervention
- Heart Disease, Coronary
- VITALYST System
- (no location specified)
Nov 9, 2023
High-risk Percutaneous Coronary Intervention Trial in New York (The Elevate™ System)
Not yet recruiting
- High-risk Percutaneous Coronary Intervention
- The Elevate™ System
-
New York, New YorkNew York-Presbyterian Hospital/Columbia University Irving Medica
Feb 3, 2023
Sustained VT Trial in United States (cryoablation procedure)
Not yet recruiting
- Sustained VT
- cryoablation procedure
-
Phoenix, Arizona
- +3 more
Jan 5, 2023
Adenosine Deaminase Severe Combined Immune Deficiency Trial (A cryopreserved formulation of autologous mPB CD34+ hematopoietic
Not yet recruiting
- Adenosine Deaminase Severe Combined Immune Deficiency
- A cryopreserved formulation of autologous mPB CD34+ hematopoietic stem and progenitor cells transduced ex vivo with the EFS-ADA lentiviral vector encoding the human ADA enzyme
- (no location specified)
Jun 20, 2022
Ventricular Tachycardia, Arrythmia, Heart Diseases Trial in Maywood, Rochester, Nashville (Saline Enhanced Radiofrequency (SERF)
Completed
- Ventricular Tachycardia
- +3 more
- Saline Enhanced Radiofrequency (SERF) ablation
-
Maywood, Illinois
- +2 more
Aug 5, 2022
Transhumeral Amputation Trial in Salt Lake City (PODS)
Not yet recruiting
- Transhumeral Amputation
- PODS
-
Salt Lake City, UtahVA Salt Lake City Health Care System, Salt Lake City, UT
Oct 6, 2022
Vasovagal Reaction Trial in Lyon (Psychological strategy, Physiological strategy)
Not yet recruiting
- Vasovagal Reaction
- Psychological strategy
- Physiological strategy
-
Lyon, FranceFrench Blood Establishment (EFS)
Aug 25, 2023
Mitral Valve Regurgitation, Mitral Valve Prolapse, Mitral Valve Insufficiency Trial in Krakow, Warsaw (Harpoon Medical Device)
Completed
- Mitral Valve Regurgitation
- +2 more
- Harpoon Medical Device
-
Krakow, Poland
- +1 more
Mar 21, 2022
Patients Previously Treated With Autologous ex Vivo Gene Therapy
Enrolling by invitation
- Adenosine Deaminase Deficiency
- Severe Combined Immunodeficiency (SCID)
- autologous ex vivo gene therapy products based on the EFS LV encoding for the human adenosine deaminase (ADA) gene (EFS-ADA LV)
-
Los Angeles, California
- +1 more
Mar 31, 2022
Neurologic Disorder, Paralysis, Paralysis; Stroke Trial in Sydney, Brisbane, Melbourne (Motor Neuroprosthesis)
Recruiting
- Neurologic Disorder
- +9 more
- Motor Neuroprosthesis
-
Sydney, New South Wales, Australia
- +2 more
Jun 20, 2022
Neurologic Disorder Trial in Melbourne (StentrodeTM)
Completed
- Neurologic Disorder
- Stentrode
-
Melbourne, Victoria, AustraliaRoyal Melbourne Hospital
Aug 29, 2022
Severe Combined Immunodeficiency Due to ADA Deficiency Trial in London (Infusion of autologous cryopreserved EFS-ADA LV CD34+
Active, not recruiting
- Severe Combined Immunodeficiency Due to ADA Deficiency
- Infusion of autologous cryopreserved EFS-ADA LV CD34+ cells (OTL-101)
- +2 more
-
London, United KingdomGreat Ormond Street Hospital for Children NHS Foundation Trust
Dec 17, 2021
Tricuspid Regurgitation Trial in New York, Charlottesville (Transcatheter Tricuspid Valve Replacement)
Not yet recruiting
- Tricuspid Regurgitation
- Transcatheter Tricuspid Valve Replacement
-
New York, New York
- +1 more
Nov 2, 2021
Mitral Regurgitation Trial in United States (CardioMech MVRS)
Active, not recruiting
- Mitral Regurgitation
- CardioMech MVRS
-
Wichita, Kansas
- +5 more
Mar 28, 2022
Ischemic Stroke Trial in Buffalo (thrombectomy)
Recruiting
- Ischemic Stroke
- thrombectomy
-
Buffalo, New Yorkkaledia Health/Buffalo General Medical Center/GVI
Aug 19, 2021
Neurologic Disorder, Paralysis, Paralysis; Stroke Trial in New York (Motor Neuroprosthesis (MNP))
Recruiting
- Neurologic Disorder
- +11 more
- Motor Neuroprosthesis (MNP)
-
New York, New YorkMount Sinai Health System
Aug 1, 2022
Peripheral Arterial Disease Trial in Jerusalem, Petah tikva, Tel Aviv (ChampioNIR® SFA Stent)
Active, not recruiting
- Peripheral Arterial Disease
- ChampioNIR® SFA Stent
-
Jerusalem, Israel
- +2 more
Aug 31, 2021
Tricuspid Regurgitation Functional Trial in Hackensack, New York (CI Percutaneous Ring Annuloplasty System)
Recruiting
- Tricuspid Regurgitation Functional
- CI Percutaneous Ring Annuloplasty System
-
Hackensack, New Jersey
- +1 more
Nov 18, 2021
Access HBV Assays - European Union Clinical Trial Protocol -
Recruiting
- HBV
- Access HBV serological marker assays on the DxI 9000 Access Immunoassay Analyzer and CE-marked predicate assays
-
Amiens, France
- +4 more
Jun 23, 2022
Diffuse Large B Cell Lymphoma Trial in France (Adapted physical activity)
Recruiting
- Diffuse Large B Cell Lymphoma
- Adapted physical activity
-
Besançon, France
- +4 more
Oct 7, 2021
Adenosine Deaminase Deficiency, Severe Combined Immunodeficiencies (SCID) Trial in London (genetic, other, drug)
Completed
- Adenosine Deaminase Deficiency
- Severe Combined Immunodeficiencies (SCID)
- Infusion of autologous EFS-ADA LV CD34+ cells
- +3 more
-
London, United KingdomGreat Ormond Street Hospital for Children NHS Foundation Trust
Aug 20, 2021
Access Anti-HCV Assay European Union Clinical Trial Protocol
Completed
- HCV
- Access HCV
-
Bois-Guillaume, France
- +2 more
Jul 12, 2021
Access HIV Ag/Ab Combo Assay - European Union Clinical Trial
Active, not recruiting
- HIV I Infection
- HIV-2 Infection
- Access HIV_blood donor
- +7 more
-
Bois-Guillaume, France
- +4 more
Jun 23, 2022
Aortic Valve Stenosis, Heart Valve Diseases, Heart Diseases Trial in Worldwide (JenaValve Pericardial TAVR System)
Active, not recruiting
- Aortic Valve Stenosis
- +4 more
- JenaValve Pericardial TAVR System
-
Los Angeles, California
- +13 more
Mar 21, 2022
Stroke Trial in Grenoble (Adipose Derived Stem Cells, Vehicle media)
Withdrawn
- Stroke
- Adipose Derived Stem Cells
- Vehicle media
-
Grenoble, FranceUniversity Grenoble Hospital / EFS
Sep 28, 2021